News | January 25, 2024
Shilpa Medicare directed to to pay damage to Celltrion
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
US FDA approval based on NEURO-TTRansform Phase III results
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
Subscribe To Our Newsletter & Stay Updated
